Trial Profile
The relative bioavailability of rilpivirine following administration of Single-tablet regimens (STRs): rilpivirine/emtricitabine/tenofovir alafenamide vs rilpivirine/emtricitabine/tenofovir disoproxil fumarate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir alafenamide (Primary) ; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics